Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
暂无分享,去创建一个
N. Scichilone | G. Scioscia | R. Campisi | C. Crimi | C. Pelaia | N. Crimi | G. Pelaia | A. Benfante | M. Caiaffa | G. Valenti | E. Buonamico | F. Papia | S. Nolasco | A. Portacci | Alessandra Tomasello | Aikaterini Detoraki | Giuseppe Spadaro | G. E. Carpagnano | Massimo Triggiani